Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 809 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Inpatient Mammography May Help Solve Issue of Low Screening Rates, Especially... July 12, 2021 Molecular Profiling with Targeted Panel Tests that Includes Fusion Detection Has... July 13, 2022 ESMO Sarcoma and Rare Cancers Congress 2024 March 5, 2024 Working towards equal cancer care for everyone August 2, 2023 Load more HOT NEWS The Winter Solstice FDA Approves Palbociclib with Trastuzumab, With or Without Pertuzumab, and Endocrine... Osimertinib After Definitive Chemoradiotherapy Prolongs PFS in Patients with Unresectable Stage... Reflections from our chief clinician: The essential role of our research...
